[1] Pardoll D M. The blockade of immune checkpoints in cancer immunotherapy[J]. Nature Reviews, Cancer, 2012, 12: 252-264.
[2] Morens D M, Folkers G K, Fauci A S. The challenge of emerging and re-emerging infectious diseases[J]. Nature, 2004, 430: 242-249.
[3] Tognotti E. The eradication of smallpox, a success story for modern medicine and public health: What lessons for the future?[J]. Journal of Infection in Developing Countries, 2010, 4: 264-266.
[4] Gross C P, Sepkowitz K A. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered[J]. International Journal of InfectiousDiseases: Official Publication of the International Society for Infectious Diseases, 1998, 3: 54-60.
[5] Stearns R P, Pasti G, Jr. Remarks upon the introduction of inoculation for smallpox in England[J]. Bulletin of the History of Medicine, 1950, 24: 103-122.
[6] Willis N J. Edward Jenner and the eradication of smallpox[J]. Scottish Medical Journal, 1997, 42: 118-121.
[7] Couzin-Frankel J. Breakthrough of the year 2013: Cancer Immunotherapy[J]. Science, 2013, 342: 1432-1433.
[8] Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age[J]. Nature, 2011, 480: 480-489.
[9] Pardoll D M. Spinning molecular immunology into successful immunotherapy[J]. Nature Reviews Immunology, 2002, 2: 227-238.
[10] Conforti-Andreoni C, Ricciardi-Castagnoli P, Mortellaro A. The inflammasomes in health and disease: From genetics to molecular mechanisms of autoinflammation and beyond[J]. Cellular & Molecular Immunology, 2011, 8: 135-145.
[11] Miao E A, Leaf I A, Treuting P M, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria[J]. NatureImmunology, 2010, 11: 1136-1142.
[12] Schroder K, Tschopp J. The inflammasomes[J]. Cell, 2010, 140: 821-832.
[13] Mariathasan S, Weiss D S, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP[J]. Nature, 2006, 440: 228-232.
[14] Hu Y, Mao K, Zeng Y, et al. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production[J]. Journal of Immunology, 2010, 185: 7699-7705.
[15] Kayagaki N, Stowe I B, Lee B L, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J]. Nature, 2015, 526: 666-671.
[16] Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526: 660-665.
[17] He W T, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion[J]. Cell Research, 2015, 25: 1285-1298.